Akari Therapeutics Plc (AKTX)
11.47
+0.63
(+5.81%)
USD |
NASDAQ |
Sep 04, 16:00
11.63
+0.16
(+1.39%)
After-Hours: 20:00
Akari Therapeutics Cash and Short Term Investments (Annual) : 5.263M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 5.263M |
| December 31, 2024 | 2.659M |
| December 31, 2023 | 3.845M |
| December 31, 2022 | 13.25M |
| December 31, 2021 | 9.361M |
| December 31, 2020 | 14.06M |
| December 31, 2019 | 5.732M |
| December 31, 2018 | 5.446M |
| Date | Value |
|---|---|
| December 31, 2017 | 28.11M |
| December 31, 2016 | 44.59M |
| December 31, 2015 | 68.92M |
| December 31, 2014 | 6.306M |
| December 31, 2013 | 7.657M |
| December 31, 2012 | 1.104M |
| December 31, 2011 | 0.006M |
| December 31, 2010 | 0.0091M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| DBV Technologies SA | 194.17M |
| Cellectis SA | 208.66M |
| argenx SE | 4.440B |
| Autolus Therapeutics Plc | 302.21M |
| Evaxion AS | 23.23M |